A list of previous webinars can be found on ASCLS Labucate under Past Live Events.
April 29, 1 pm ET
Sickle Cell Anemia – Blood Product Allocation and Future Therapies

Description: The presentation will begin with a description of hemoglobinopathies (particularly hemoglobin SS and SC disease) and the recommendations for blood bank products. It introduces what Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is and how it is employed. CRISPR’s use in patients with sickle cell anemia will be explained. Lastly, CRISPR-edited CAR-T cell therapy will be briefly introduced.
Objectives:
- Identify hemoglobinopathies that have blood bank recommendations in blood allocation
- Describe the reasoning for the blood bank product recommendations
- Explain the methodology of CRISPR and it’s application to hemoglobinopathies
- Introduce CRISPR-edited CAR-T cell therapy
Instruction Level: Basic
Registration: Free for ASCLS members; $10 for non-members (guests).
Learn about a new topic and earn 1 P.A.C.E.® credit per webinar. All upcoming webinars are free for ASCLS members ($10 for nonmembers or customers). If you can’t attend live, register anyway—those who pre-register will receive access to the webinar recording.